180 Life Sciences Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)
PALO ALTO, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the...
News
Alignment Healthcare Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance
ORANGE, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Medicare Advantage company (NASDAQ: ALHC) Alignment Healthcare today announced that its core...
Mindset Pharma Announces Appointment of Clinician Scientist, Dr. Ishrat Husain, to Scientific Advisory Board
TORONTO, July 20, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"),...
Beyond Air® Schedules First Fiscal Quarter 2022 Financial Results Conference Call and Webcast
Call scheduled for Tuesday, August 10th at 4:30 pm Eastern TimeGARDEN CITY, N.Y., July 20, 2021 (GLOBE NEWSWIRE) -- Beyond...
SpringWorks Therapeutics Announces Issuance of New U.S. Composition of Matter Patent to Polymorphic Form of Mirdametinib, Extending Patent Protection Into 2041
STAMFORD, Conn., July 20, 2021 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) announced today that the United States Patent...
AREV Annual and Special General Meeting Results
Appoints Mel Maxwell as an AREV DirectorVANCOUVER, British Columbia, July 20, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE:...
Affinia Therapeutics Announces Collaboration with the Institute of Molecular and Clinical Ophthalmology Basel (IOB) To Rationally Design Novel CNS Promoters for Gene Therapy
– Botond Roska, M.D., Ph.D., world-renowned scientist and Director at IOB and scientific co-founder of Affinia Therapeutics, will oversee collaboration – –...
Novartis pledges 10-year commitment with Morehouse School of Medicine, 26 Historically Black Colleges, Universities, Medical Schools and other leading organizations to co-create effective, measurable solutions for health equity
Novartis and the Novartis US Foundation to join forces with Thurgood Marshall College Fund, Morehouse School of Medicine, 26 other...
Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on August 4th, 2021
NESS ZIONA, Israel, July 20, 2021 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (Nasdaq: SLGL), a clinical-stage dermatology company focused on...
Pacific Biosciences and Invitae Announce Intent to Expand Collaboration
Collaboration to develop production-scale HiFi Sequencing platformexpected to Include technology from Omniome, Inc. Combining both highly accurate long and short...
Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer
Dr. Dybul’s Deep and Prestigious Scientific Research Expertise Helps to Affirm Enochian BioSciences’ Scientific ApproachLOS ANGELES, July 20, 2021 (GLOBE NEWSWIRE)...
Venus Concept Announces Health Canada Authorization and CE Mark for Venus Fiore® Feminine Health System
TORONTO, July 20, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
Longitude Capital Raises Inaugural Opportunities Fund with $135 Million to Invest in Breakout Healthcare Companies
- Longitude Prime Fund makes first investment in IPO of Rapid Micro Biosystems, the industry leading automated quality-control platform for pharmaceutical...
EyePoint Pharmaceuticals Receives Preliminary Extension to Pass-Through Payment Status for DEXYCU®
WATERTOWN, Mass., July 20, 2021 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and...
Jushi Holdings Inc. Announces the Expiration of HSR Act Waiting Period for the Proposed Acquisition of Nature’s Remedy of Massachusetts, Inc.
BOCA RATON, Fla., July 20, 2021 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF),...
Global WholeHealth Partners Corp (OTC:GWHP) Receives a Second Order for 10,000 Tests From Salud Previa of Tijuana, MX; Salud Previa has Ordered Over 30,000 Tests Now; Tests Sold Were Pregnancy Tests, Drug Tests, Dengue Fever, TB and COVID
San Clemente, CA, July 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global WholeHealth Partners Corp (OTC:GWHP) will be selling...
Progressive Care Announces Full Launch of New COVID-19 Digital Passport App
MIAMI, FL, July 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”),...
MediWound Announces Positive Topline Results from Phase 3 Pediatric Study (CIDS) of NexoBrid for Eschar Removal of Severe Thermal Burns
Primary Endpoints Met with Highly Statistically Significant Results Compared with Standard-of-CareYAVNE, Israel, July 20, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd....
Clearmind Issues Shareholder Letter
Toronto, July 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire-- Clearmind Medicine Inc. (CSE: CMND) ("Clearmind" or the "Company"), a psychedelic...
ADMA Biologics Announces Successful Completion of FDA Pre-Approval Manufacturing Facility Inspection
Approval for VanRx Fill-Finish Machine Expected in the Second Half of 2021 All Supply Chain Robustness Initiatives Remain on Schedule...